Professional Documents
Culture Documents
Multi drug resistant bacteria are found in our surroundings and it is not restricted only to
clinical samples but also seen on fruits, vegetables, soil and waste water. MDR bacteria
were isolated on EMB medium from suspected patients urine sample and subjected
genomic DNA was isolated and amplified using adapters such as EcoRi and Msel
with the help of AFLP technique and their genetic variation was studied.
INTRODUCTION
Bacteria existed on earth for 3 billion years and became adapted for
protecting themselves against toxic chemicals. Antibiotics were in clinical use for
more than six decades and overuse of those antibiotics resulted in multiple drug
resistance in microbes and thus none of the antibiotics killed microbes (Varsha
Shriram et al., 2013). Bacteria are found in every possible habitat on the planet
and they adapt to changes in external factors which is essential for their survival
become resistant by mutation or due to the effect of new genes. Some bacterial
species are inherently resistant to certain antibiotics, whereas others are sensitive.
Sensitivity has three requirements: a target for reaction, a mechanism for transport
into the cell before the antibiotic action takes place and absence of enzymes that
Staphylococcus aureus plate and that it had particular group of compounds which
could be used to treat infection effectively. This kind of compounds were later
World War II stimulated the beginning of the antibiotic era (Weiss and Michael,
2004). Till 1960s, more than 100 antibiotics became commercially available and
were used extensively in the treatment of infectious disease. This period of time
synthesis of cell wall, DNA, RNA, protein, cell growth, and cell division (Mingeot
Leclereq et al., 1999). Antibiotics isolated from microorganisms were used earlier
and later compounds derived or synthesized from natural products were used.
Large scale usage of antibiotics in animal faming led to its accumulation in food
chain and organisms developed resistance to drugs. Such organisms are called
multi drug resistant organisms which created a threat in public health (Koehn and
Carter, 2005).
of microorganisms will increase if the selective antibiotic use continues and the
resistant organism is able to spread from one person to another. Gram-positive and
Gram-negative bacteria are both affected by the effect of antimicrobial resistance
anaerobic gram negative bacilli. It was discovered by Werkman and Gilen in 1932
and it is found in soil organism, water, sewage, food and in the intestinal tracts of
the activities of the enzyme like gyrase and polymerases in DNA synthesis.
attacks the channels on the membrane which are responsible for the creation
hands of direct care workers. Transmission from direct or indirect contact with
infected patients and their environment. Contact transmission is the primary mode
of spread for MDRO. Surfaces and equipment can also become reservoirs of
transmission may be implicated in the spread of MDRO when the patient has a
Untreatable infections
Costs
new antimicrobial agents that are in development. MDR is severe with patients
having high morbidity score and mortality rate often with unusual
Each gene has a particular place along the chromosome called locus. Due to
mutations, genes can be modified in several forms called alleles (or allelic forms).
Molecular markers are loci markers related to DNA (markers can also be
biochemical, or morphological) and AELP is one such molecular marker. They are
electrophoresis and the DNA fragments obtained range from 60 to 500 base pairs.
can amplify specific DNA fragment by using specific primers for polymerization
at each end of the target DNA. Primer (short oligonucleotide sequences) anneal to
the template DNA in the target zone. Primers are 18-24 base pairs long and
primers will bind to the template DNA. Taq polymerase will recognizes each
the target DNA must be known. The AFLP primers are called adapters and
total genomic DNA by the combined action of two restriction enzymes. Adapters
adapters are used in a PCR as priming sites to amplify the restriction fragments.
fragment.
Wolfenbarger, 1999).